Kuros appoints Dr. Fritz Kunz as chairman of the the company board
New Chief Operating Officer to Join Executive Management Team
Kuros AG announced the appointment of Dr Fritz Kunz as Chairman of the Company Board and Dr Edward Currie as Chief Operating Officer.
Dr Fritz Kunz is an industry professional, having held senior operating and Board positions at a number of medical technology and biotechnology companies. He is currently a Board Member of two Swiss companies, Speedel, where he acts as Chairman and SenTec. Dr Kunz was previously the CEO and a Board Member of Institut Straumann AG. Before joining Straumann in 1994, Dr Kunz was Head of Finance and Administration at STRATEC Medical. Dr Kunz's earlier career was spent at Sandoz Pharma AG, where he held positions of increasing responsibility and seniority.
Dr Edward Currie, who joined Kuros earlier this year, also brings a solid background in Pharma and Biotech. A British-trained medical doctor, Dr Currie has 19 years of international Pharma experience, with F.Hoffmann-La Roche in global positions including Medical Director of the Biotech Business Unit, Global Business Leader for the monoclonal antibody MabThera(r), and Head of Disease Management; at Eli Lilly, as International Clinical Research Physician and at IBM as a managing consultant in pharmaceuticals.
Organizations
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.